Insider · CIK 0001615842
Barry P Flannelly
Files at INCY (INCYTE CORP), TARA (Protara Therapeutics, Inc.). First filing Nov 8, 2024, latest Mar 18, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
INCY: INCYTE CORP
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 38Weak | INCYTE CORP | $1.3M 19,807 shares | -37% | - | |
| 0Weak | INCYTE CORP | $293k 3,680 shares | -6% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 12, 2025 | TARA Protara Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +24,000 | $0.00 | $0 | 24,000 | Jun 13, 2025 |
| Apr 1, 2025 | INCY INCYTE CORP | AGrant or award Common Stock | +11,159 | $0.00 | $0 | 44,726 | Apr 3, 2025 |
| Apr 1, 2025 | INCY INCYTE CORP | AGrant or award Common Stock | +14,976 | $0.00 | $0 | 59,702 | Apr 3, 2025 |
| Mar 14, 2025 | INCY INCYTE CORP | SOpen-market sale Common Stock10b5-1 | -461 | $67.85 | $31k | 52,913 | Mar 18, 2025 |
| Mar 14, 2025 | INCY INCYTE CORP | SOpen-market sale Common Stock10b5-1 | -199 | $67.88 | $14k | 52,714 | Mar 18, 2025 |
| Mar 14, 2025 | INCY INCYTE CORP | SOpen-market sale Common Stock10b5-1 | -19,147 | $67.68 | $1.3M | 33,567 | Mar 18, 2025 |
| Jan 17, 2025 | INCY INCYTE CORP | AGrant or award Employee Stock Option (right to buy)derivative | +20,144 | $0.00 | $0 | 20,144 | Jan 22, 2025 |
| Jan 15, 2025 | INCY INCYTE CORP | FTax withholding Common Stock | -3,158 | $72.46 | $229k | 53,374 | Jan 17, 2025 |
| Dec 9, 2024 | INCY INCYTE CORP | FTax withholding Common Stock | -1,510 | $72.11 | $109k | 56,532 | Dec 11, 2024 |
| Nov 6, 2024 | INCY INCYTE CORP | MOption exercise Common Stock10b5-1 | +1,424 | $72.27 | $103k | 59,466 | Nov 8, 2024 |
| Nov 6, 2024 | INCY INCYTE CORP | MOption exercise Common Stock10b5-1 | +2,256 | $68.62 | $155k | 61,722 | Nov 8, 2024 |
| Nov 6, 2024 | INCY INCYTE CORP | SOpen-market sale Common Stock10b5-1 | -1,424 | $82.00 | $117k | 60,298 | Nov 8, 2024 |
| Nov 6, 2024 | INCY INCYTE CORP | SOpen-market sale Common Stock10b5-1 | -2,256 | $78.21 | $176k | 58,042 | Nov 8, 2024 |
| Nov 6, 2024 | INCY INCYTE CORP | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -1,424 | $0.00 | $0 | 0 | Nov 8, 2024 |
| Nov 6, 2024 | INCY INCYTE CORP | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -2,256 | $0.00 | $0 | 0 | Nov 8, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.